CBX7 and breast cancer: Reduced expression levels of CBX7 have been found to be associated with a poorer OS and the aggressiveness of thyroid cancers, colorectal cancers and breast cancers (42–44), In HCC, the downregulation of CBX7 may be related to a short OS (17).